APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rare Genetic Disease Diagnosis Solution

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rare Genetic Disease Diagnosis Solution Industry Growth and Trends Forecast to 2032

Report ID 174226420111 April 2026103 pages

Choose your research edition.

Industry ResearchRare Genetic Disease Diagnosis Solution Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Genetic Disease Diagnosis Solution Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Rare Genetic Disease Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Genetic Disease Diagnosis Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Rare Genetic Disease Diagnosis Solution Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

According to APO Research, the global Rare Genetic Disease Diagnosis Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rare Genetic Disease Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Rare Genetic Disease Diagnosis Solution market include Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina and PerkinElmer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rare Genetic Disease Diagnosis Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rare Genetic Disease Diagnosis Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rare Genetic Disease Diagnosis Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rare Genetic Disease Diagnosis Solution.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Rare Genetic Disease Diagnosis Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rare Genetic Disease Diagnosis Solution Market by Company

Retrophin

3billion

23andMe

Ancestry

GeneDx

Ambry Genetics

QIAGEN

Illumina

PerkinElmer

Strand Life Sciences

Rare Genetic Disease Diagnosis Solution Segment by Type

Genetic Testing

Biochemical Testing

Imaging and Diagnostic Procedures

Others

Rare Genetic Disease Diagnosis Solution Segment by Application

Clinical Genetics and Pediatric Clinic

Newborn Screening Program

Research and Development

Others

Rare Genetic Disease Diagnosis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Genetic Disease Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Genetic Disease Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Genetic Disease Diagnosis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Rare Genetic Disease Diagnosis Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Rare Genetic Disease Diagnosis Solution Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2021-2026) Table 4. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2027-2032) Table 6. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2026) Table 9. Global Rare Genetic Disease Diagnosis Solution Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Rare Genetic Disease Diagnosis Solution Market Size Share Forecasted by Type (2027-2032) Table 11. North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2026) Table 24. Global Rare Genetic Disease Diagnosis Solution Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Rare Genetic Disease Diagnosis Solution Market Size Share Forecasted by Application (2027-2032) Table 26. North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Rare Genetic Disease Diagnosis Solution Industry Trends Table 37. Rare Genetic Disease Diagnosis Solution Industry Drivers Table 38. Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges Table 39. Rare Genetic Disease Diagnosis Solution Industry Restraints Table 40. Global Rare Genetic Disease Diagnosis Solution Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Company (2021-2026) Table 42. Global Rare Genetic Disease Diagnosis Solution Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Rare Genetic Disease Diagnosis Solution Key Company Headquarters & Area Served Table 44. Global Rare Genetic Disease Diagnosis Solution Company, Product Type & Application Table 45. Global Rare Genetic Disease Diagnosis Solution Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Rare Genetic Disease Diagnosis Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Retrophin Company Information Table 49. Retrophin Business Overview Table 50. Retrophin Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio Table 52. Retrophin Recent Development Table 53. 3billion Company Information Table 54. 3billion Business Overview Table 55. 3billion Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio Table 57. 3billion Recent Development Table 58. 23andMe Company Information Table 59. 23andMe Business Overview Table 60. 23andMe Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio Table 62. 23andMe Recent Development Table 63. Ancestry Company Information Table 64. Ancestry Business Overview Table 65. Ancestry Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio Table 67. Ancestry Recent Development Table 68. GeneDx Company Information Table 69. GeneDx Business Overview Table 70. GeneDx Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio Table 72. GeneDx Recent Development Table 73. Ambry Genetics Company Information Table 74. Ambry Genetics Business Overview Table 75. Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio Table 77. Ambry Genetics Recent Development Table 78. QIAGEN Company Information Table 79. QIAGEN Business Overview Table 80. QIAGEN Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio Table 82. QIAGEN Recent Development Table 83. Illumina Company Information Table 84. Illumina Business Overview Table 85. Illumina Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio Table 87. Illumina Recent Development Table 88. PerkinElmer Company Information Table 89. PerkinElmer Business Overview Table 90. PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio Table 92. PerkinElmer Recent Development Table 93. Strand Life Sciences Company Information Table 94. Strand Life Sciences Business Overview Table 95. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio Table 97. Strand Life Sciences Recent Development Table 98. North America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2026) Table 101. North America Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Rare Genetic Disease Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 103. Europe Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2026) Table 106. Europe Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Rare Genetic Disease Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2026) Table 111. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 113. Latin America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2026) Table 116. Latin America Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Rare Genetic Disease Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2026) Table 121. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Rare Genetic Disease Diagnosis Solution Product Image Figure 3. Global Rare Genetic Disease Diagnosis Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Rare Genetic Disease Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 5. Global Rare Genetic Disease Diagnosis Solution Market Share by Region: 2025 VS 2032 Figure 6. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2021-2032) Figure 7. North America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Genetic Testing Image Figure 13. Global Genetic Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Biochemical Testing Image Figure 15. Global Biochemical Testing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Imaging and Diagnostic Procedures Image Figure 17. Global Imaging and Diagnostic Procedures Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Rare Genetic Disease Diagnosis Solution Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Rare Genetic Disease Diagnosis Solution Market Share by Type 2025 VS 2032 Figure 22. North America Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032) Figure 23. Europe Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032) Figure 25. Latin America Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Share by Type (2021-2032) Figure 27. Clinical Genetics and Pediatric Clinic Image Figure 28. Global Clinical Genetics and Pediatric Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Newborn Screening Program Image Figure 30. Global Newborn Screening Program Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Research and Development Image Figure 32. Global Research and Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Rare Genetic Disease Diagnosis Solution Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Rare Genetic Disease Diagnosis Solution Market Share by Application 2025 VS 2032 Figure 37. North America Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032) Figure 38. Europe Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032) Figure 40. Latin America Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Rare Genetic Disease Diagnosis Solution Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Rare Genetic Disease Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Rare Genetic Disease Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 47. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Rare Genetic Disease Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 50. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 53. Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Rare Genetic Disease Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 56. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Genetic Testing
  • Biochemical Testing
  • Imaging and Diagnostic Procedures
  • Others
Applications
  • Clinical Genetics and Pediatric Clinic
  • Newborn Screening Program
  • Research and Development
  • Others
Companies covered
  • Retrophin
  • 3billion
  • 23andMe
  • Ancestry
  • GeneDx
  • Ambry Genetics
  • QIAGEN
  • Illumina
  • PerkinElmer
  • Strand Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Rare Genetic Disease Diagnosis Solution Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2032)
  5. 1.4.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2021-2026)
  6. 1.4.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2027-2032)
  7. 1.5 Key Regions Rare Genetic Disease Diagnosis Solution Market Size (2021-2032)
  8. 1.5.1 North America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (2021-2032)
2 Rare Genetic Disease Diagnosis Solution Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Genetic Testing
  3. 2.1.2 Biochemical Testing
  4. 2.1.3 Imaging and Diagnostic Procedures
  5. 2.1.4 Others
  6. 2.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Type
  7. 2.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Rare Genetic Disease Diagnosis Solution Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Rare Genetic Disease Diagnosis Solution Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Rare Genetic Disease Diagnosis Solution Market Size by Regions
  11. 2.3.1 North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Type (2021-2026)
3 Rare Genetic Disease Diagnosis Solution Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinical Genetics and Pediatric Clinic
  3. 3.1.2 Newborn Screening Program
  4. 3.1.3 Research and Development
  5. 3.1.4 Others
  6. 3.2 Global Rare Genetic Disease Diagnosis Solution Market Size by Application
  7. 3.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Rare Genetic Disease Diagnosis Solution Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Rare Genetic Disease Diagnosis Solution Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Rare Genetic Disease Diagnosis Solution Market Size by Regions
  11. 3.3.1 North America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Rare Genetic Disease Diagnosis Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Rare Genetic Disease Diagnosis Solution Industry Trends
  2. 4.2 Rare Genetic Disease Diagnosis Solution Industry Drivers
  3. 4.3 Rare Genetic Disease Diagnosis Solution Industry Opportunities and Challenges
  4. 4.4 Rare Genetic Disease Diagnosis Solution Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Rare Genetic Disease Diagnosis Solution Revenue (2021-2026)
  2. 5.2 Global Rare Genetic Disease Diagnosis Solution Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Rare Genetic Disease Diagnosis Solution Key Company Headquarters & Area Served
  4. 5.4 Global Rare Genetic Disease Diagnosis Solution Company, Product Type & Application
  5. 5.5 Global Rare Genetic Disease Diagnosis Solution Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Rare Genetic Disease Diagnosis Solution Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Rare Genetic Disease Diagnosis Solution Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Rare Genetic Disease Diagnosis Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Retrophin
  2. 6.1.1 Retrophin Company Information
  3. 6.1.2 Retrophin Business Overview
  4. 6.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Retrophin Rare Genetic Disease Diagnosis Solution Product Portfolio
  6. 6.1.5 Retrophin Recent Developments
  7. 6.2 3billion
  8. 6.2.1 3billion Company Information
  9. 6.2.2 3billion Business Overview
  10. 6.2.3 3billion Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 3billion Rare Genetic Disease Diagnosis Solution Product Portfolio
  12. 6.2.5 3billion Recent Developments
  13. 6.3 23andMe
  14. 6.3.1 23andMe Company Information
  15. 6.3.2 23andMe Business Overview
  16. 6.3.3 23andMe Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 23andMe Rare Genetic Disease Diagnosis Solution Product Portfolio
  18. 6.3.5 23andMe Recent Developments
  19. 6.4 Ancestry
  20. 6.4.1 Ancestry Company Information
  21. 6.4.2 Ancestry Business Overview
  22. 6.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Ancestry Rare Genetic Disease Diagnosis Solution Product Portfolio
  24. 6.4.5 Ancestry Recent Developments
  25. 6.5 GeneDx
  26. 6.5.1 GeneDx Company Information
  27. 6.5.2 GeneDx Business Overview
  28. 6.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 GeneDx Rare Genetic Disease Diagnosis Solution Product Portfolio
  30. 6.5.5 GeneDx Recent Developments
  31. 6.6 Ambry Genetics
  32. 6.6.1 Ambry Genetics Company Information
  33. 6.6.2 Ambry Genetics Business Overview
  34. 6.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Ambry Genetics Rare Genetic Disease Diagnosis Solution Product Portfolio
  36. 6.6.5 Ambry Genetics Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 QIAGEN Rare Genetic Disease Diagnosis Solution Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Illumina
  44. 6.8.1 Illumina Company Information
  45. 6.8.2 Illumina Business Overview
  46. 6.8.3 Illumina Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Illumina Rare Genetic Disease Diagnosis Solution Product Portfolio
  48. 6.8.5 Illumina Recent Developments
  49. 6.9 PerkinElmer
  50. 6.9.1 PerkinElmer Company Information
  51. 6.9.2 PerkinElmer Business Overview
  52. 6.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 PerkinElmer Rare Genetic Disease Diagnosis Solution Product Portfolio
  54. 6.9.5 PerkinElmer Recent Developments
  55. 6.10 Strand Life Sciences
  56. 6.10.1 Strand Life Sciences Company Information
  57. 6.10.2 Strand Life Sciences Business Overview
  58. 6.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product Portfolio
  60. 6.10.5 Strand Life Sciences Recent Developments
7 North America
  1. 7.1 North America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  3. 7.3 North America Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  3. 8.3 Europe Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  3. 10.3 South America Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst